Buy Ajanta Pharma, target price Rs 2030: ICICI Securities
Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2023.

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 24596.36 Crore) operating in Pharmaceuticals sector.
Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2023.
Financials
For the quarter ended 30-09-2023, the company reported a Consolidated Total Income of Rs 1049.77 Crore, down -.29 % from last quarter Total Income of Rs 1052.79 Crore and up 7.29 % from last year same quarter Total Income of Rs 978.45 Crore. Company reported net profit after tax of Rs 195.30 Crore in latest quarter.
Promoters held 66.21 per cent stake in the company as of 30-Sep-2023, while FIIs owned 9.99 per cent, DIIs 15.6 per cent.
Download ET Markets APP